← FDA Drug Approvals (Drugs@FDA)

AMPYRA

NDA · New Drug Application · Sponsor: MERZ · Approved 2010-01-22

Drug application

FDA Application #

NDA022250

Application type

New Drug Application

Brand name

AMPYRA

Generic name

DALFAMPRIDINE

Active ingredients

DALFAMPRIDINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

MERZ

Manufacturer

Merz Pharmaceuticals, LLC

First approval

2010-01-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown